Upon completion of the video presentation, to finish the activity and claim your credit, please click
here.
This activity has expired, credit is no longer available.
This activity is supported by an independent educational grant from Merck Sharp & Dohme Corp.
Advances in the Management of Patients with Urothelial Carcinomas of the Bladder
Emily Lemke, DNP, AGPCNP-BC, AOCNP®
The University of Texas MD Anderson Cancer Center
Amishi Shah, MD
The University of Texas MD Anderson Cancer Center
Get an update on the state of chemotherapy and immunotherapy for the treatment of urothelial carcinomas of the bladder. Learn how these therapies combat the various types of urothelial carcinomas and how to identify their most common side effects, including immune-related adverse effects from immunotherapy.
These CME/CE/CPE accredited activities are jointly provided by
